Form 8-K aTYR PHARMA INC For: May 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
aTyr Pharma (LIFE) PT Lowered to $2 at BMO Capital
May 14, 2018 12:57 PM EDTBMO Capital lowered its price target on aTyr Pharma (NASDAQ: LIFE) to $2.00 (from $4.00) while maintaining a Market Perform rating.
Analyst Matthew Luchini commented, "We remain Market Perform rated following discontinuation of the ORCA I/O program, and restructuring announcement. While the restructuring... More
